Business
Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference
BURLINGTON, Mass., May 17, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual B.
About this update from Azenta, Inc.
[{"type":"text","content":"BURLINGTON, Mass., May 17, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual B. Riley Securities Institutional Investor Conference. To attend the event please contact your B. Riley Securities representative.\nAbout Azenta Life Sciences\nAzenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.\nAzenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.\nINVESTOR CONTACTS:Sara SilvermanHead of Investor Relations & Corporate [email protected]\nSherry [email protected]\n\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-23rd-annual-b-riley-securities-institutional-investor-conference-301827713.html\nSOURCE Azenta","length":2851,"tagName":"div"}]